A detailed history of Adar1 Capital Management, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 315,192 shares of RNXT stock, worth $406,597. This represents 0.05% of its overall portfolio holdings.

Number of Shares
315,192
Previous 355,240 11.27%
Holding current value
$406,597
Previous $401 Million 16.77%
% of portfolio
0.05%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.96 - $1.29 $38,446 - $51,661
-40,048 Reduced 11.27%
315,192 $334 Million
Q2 2024

Aug 13, 2024

BUY
$1.02 - $1.46 $362,344 - $518,650
355,240 New
355,240 $401 Million

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $11.7M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.